Patents by Inventor Donald E. Staunton

Donald E. Staunton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to ICAM-2, and fragments thereof
    Patent number: 5565550
    Abstract: The present invention relates to intercellular adhesion molecules (ICAM-2) which are involved in the process through which lymphocytes recognize and migrate to sites of inflammation as well as attach to cellular substrates during inflammation. The invention is directed toward such molecules, screening assays for identifying such molecules and antibodies capable of binding such molecules. The invention also includes uses for adhesion molecules and for the antibodies that are capable of binding them.
    Type: Grant
    Filed: February 10, 1994
    Date of Patent: October 15, 1996
    Assignee: Dana Farber Cancer Institute
    Inventors: Timothy A. Springer, Donald E. Staunton, Michael L. Dustin
  • Purified ICAM-2 and fragment thereof
    Patent number: 5512660
    Abstract: The present invention relates to intercellular adhesion molecules (ICAM-2) which are involved in the process through which lymphocytes recognize and migrate to sites of inflammation as well as attach to cellular substrates during inflammation. The invention is directed toward such molecules, screening assays for identifying such molecules and antibodies capable of binding such molecules. The invention also includes uses for adhesion molecules and for the antibodies that are capable of binding them.
    Type: Grant
    Filed: February 10, 1994
    Date of Patent: April 30, 1996
    Assignee: Dana Farber Cancer Institute, Inc.
    Inventors: Timothy A. Springer, Donald E. Staunton, Michael L. Dustin
  • Isolated nucleic acid molecules encoding ICAM-2
    Patent number: 5489533
    Abstract: The present invention relates to intercellular adhesion molecules (ICAM-2) which are involved in the process through which lymphocytes recognize and migrate to sites of inflammation as well as attach to cellular substrates during inflammation. The invention is directed toward such molecules, screening assays for identifying such molecules and antibodies capable of binding such molecules. The invention also includes uses for adhesion molecules and for the antibodies that are capable of binding them.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: February 6, 1996
    Assignee: Dana Farber Cancer Institute
    Inventors: Timothy A. Springer, Donald E. Staunton, Michael L. Dustin
  • Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1
    Patent number: 5288854
    Type: Grant
    Filed: November 28, 1990
    Date of Patent: February 22, 1994
    Assignee: Center For Blood Research, Inc.
    Inventors: Michael S. Diamond, Donald E. Staunton, Timothy A. Springer